Min-Chi Lai

A robust platform for expansion and genome editing of primary human natural killer cells

Steven Lin, Rih-Sheng Huang, Min-Chi Lai, 2021, The Journal of experimental medicine.

Ex Vivo Expansion and CRISPR‐Cas9 Genome Editing of Primary Human Natural Killer Cells

Steven Lin, Rih-Sheng Huang, Min-Chi Lai, 2021, Current protocols.

Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins

Steven Lin, Yao-Jen Chang, Rih-Sheng Huang, 2020, Frontiers in Immunology.

Cholesteric liquid crystal biosensor platform with image analysis for rapid detection of COVID-19

Yen-Chieh Wang, Er-Yuan Chuang, Yu-Cheng Hsiao, 2023, Frontiers in Bioengineering and Biotechnology.